Folgen
Maria Stepanova
Maria Stepanova
Director of Statistical Services, COR-LD
Bestätigte E-Mail-Adresse bei cldq.org
Titel
Zitiert von
Zitiert von
Jahr
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ...
Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011
14192011
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
ZM Younossi, D Blissett, R Blissett, L Henry, M Stepanova, Y Younossi, ...
Hepatology 64 (5), 1577-1586, 2016
12442016
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver‐related mortality
ZM Younossi, M Stepanova, N Rafiq, H Makhlouf, Z Younoszai, ...
Hepatology 53 (6), 1874-1882, 2011
7052011
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ...
Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019
6642019
Nonalcoholic fatty liver disease in lean individuals in the United States
ZM Younossi, M Stepanova, F Negro, S Hallaji, Y Younossi, B Lam, ...
Medicine 91 (6), 319-327, 2012
6262012
Adipokines and cytokines in non‐alcoholic fatty liver disease
MH Jarrar, A Baranova, R Collantes, B Ranard, M Stepanova, C Bennett, ...
Alimentary pharmacology & therapeutics 27 (5), 412-421, 2008
6162008
Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden
Z Younossi, H Park, L Henry, A Adeyemi, M Stepanova
Gastroenterology 150 (7), 1599-1608, 2016
4542016
Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population
M Stepanova, ZM Younossi
Clinical Gastroenterology and Hepatology 10 (6), 646-650, 2012
4232012
Epidemiology of chronic liver diseases in the USA in the past three decades
ZM Younossi, M Stepanova, Y Younossi, P Golabi, A Mishra, N Rafiq, ...
Gut 69 (3), 564-568, 2020
4002020
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease
N Hossain, A Afendy, M Stepanova, F Nader, M Srishord, N Rafiq, ...
Clinical Gastroenterology and Hepatology 7 (11), 1224-1229. e2, 2009
3892009
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
M Stepanova, N Rafiq, ZM Younossi
Gut 59 (10), 1410-1415, 2010
3562010
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)
ZM Younossi, M Jarrar, C Nugent, M Randhawa, M Afendy, M Stepanova, ...
Obesity surgery 18, 1430-1437, 2008
3422008
Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States
ZM Younossi, M Stepanova, J Ong, G Trimble, S AlQahtani, I Younossi, ...
Clinical Gastroenterology and Hepatology 19 (3), 580-589. e5, 2021
3352021
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)
M Stepanova, N Rafiq, H Makhlouf, R Agrawal, I Kaur, Z Younoszai, ...
Digestive diseases and sciences 58, 3017-3023, 2013
3142013
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009
M Stepanova, A Mishra, C Venkatesan, ZM Younossi
Clinical gastroenterology and hepatology 10 (9), 1034-1041. e1, 2012
2772012
Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study
L Gerber, M Otgonsuren, A Mishra, C Escheik, A Birerdinc, M Stepanova, ...
Alimentary pharmacology & therapeutics 36 (8), 772-781, 2012
2382012
NASH in lean individuals
R Younes, E Bugianesi
Seminars in liver disease 39 (01), 086-095, 2019
2282019
Predictors of health‐related quality of life in patients with chronic liver disease
A Afendy, JB Kallman, M Stepanova, Z Younoszai, RD Aquino, G Bianchi, ...
Alimentary pharmacology & therapeutics 30 (5), 469-476, 2009
2032009
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
ZM Younossi, M Stepanova, N Afdhal, KV Kowdley, S Zeuzem, L Henry, ...
Journal of hepatology 63 (2), 337-345, 2015
1932015
Caffeine is protective in patients with non‐alcoholic fatty liver disease
A Birerdinc, M Stepanova, L Pawloski, ZM Younossi
Alimentary pharmacology & therapeutics 35 (1), 76-82, 2012
1912012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20